within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H01C_HypothalamicHormones.H01CA02_Nafarelin;

model Nafarelin
  extends Pharmacolibrary.Drugs.ATC.H.H01CA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H01CA02</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nafarelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist used mainly for the treatment of endometriosis and central precocious puberty. It is administered as a nasal spray and is approved for medical use in various countries.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, both sexes, standard dosing for endometriosis</p><h4>References</h4><ol><li><p>Chrisp, P, &amp; Goa, KL (1990). Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. <i>Drugs</i> 39(4) 523–551. DOI:<a href=\"https://doi.org/10.2165/00003495-199039040-00005\">10.2165/00003495-199039040-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2140979/\">https://pubmed.ncbi.nlm.nih.gov/2140979</a></p></li><li><p>Van Leusden, HA (1994). Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose. <i>Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology</i> 8(3) 215–222. DOI:<a href=\"https://doi.org/10.3109/09513599409072458\">10.3109/09513599409072458</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7847108/\">https://pubmed.ncbi.nlm.nih.gov/7847108</a></p></li><li><p>Chan, RL, et al., &amp; Chaplin, MD (1988). Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone. <i>Clinical pharmacology and therapeutics</i> 44(3) 275–282. DOI:<a href=\"https://doi.org/10.1038/clpt.1988.150\">10.1038/clpt.1988.150</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2970910/\">https://pubmed.ncbi.nlm.nih.gov/2970910</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nafarelin;
